Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Somatrogon - OPKO Health/Pfizer

Next Previous
Drug Profile

Somatrogon - OPKO Health/Pfizer

Alternative Names: hGH-CTP; Human growth hormone-CTP; Lagova™; Long-acting CTP-enhanced human growth hormone; MOD-4023; NGENLA; PF-06836922

Latest Information Update: 10 Mar 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Modigene
  • Developer OPKO Health; Pfizer
  • Class Biological proteins; Growth hormones; Hormonal replacements; Recombinant proteins
  • Mechanism of Action Human growth hormone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Somatotropin deficiency
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Somatotropin deficiency

Most Recent Events

  • 31 Dec 2024 Preregistration for Somatotropin deficiency (In adults) in European Union (SC) before December 2024
  • 31 Dec 2024 Pfizer submits a withdrawal of MAA of Somatrogon for Somatotropin deficiency (In adults) in the European Union
  • 30 Nov 2023 OPKO Health completes a phase II trial for Somatotropin deficiency (In children) in USA, Belarus, Greece, Hungary, Russia and Ukraine (NCT02500316)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top